# A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.

> **NCT00778102** · PHASE2 · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 80 (actual)

## Conditions studied

- Colorectal Cancer

## Interventions

- **DRUG:** 5-FU
- **DRUG:** 5-FU
- **DRUG:** 5-FU
- **DRUG:** Irinotecan
- **DRUG:** Leucovorin
- **DRUG:** Leucovorin
- **DRUG:** Oxaliplatin
- **DRUG:** bevacizumab [Avastin]

## Key facts

- **NCT ID:** NCT00778102
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 80 (ACTUAL)
- **Last updated:** 2016-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778102

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778102, "A Study of Avastin (Bevacizumab) in Combination With mFOLFOX-6 or FOLFOXIRI in Patients With Metastatic Colorectal Cancer.". Retrieved via AI Analytics 2026-07-03 from https://api.ai-analytics.org/clinical/NCT00778102. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*